Stocks Wilt on Earnings and Oil Decay

The short rally in stocks was stopped on several below-average earnings reports coupled with a downturn in oil. Housing starts, however, saw a nice gain. More 

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI. More 

Bet on a Bounce with These Biotech ETFs

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain. More 

Stocks Hit Resistance as Meltup Continues

Although the markets have seemed to rebound, the Dow is still down 5.1% YTD, the S&P 500 is dealing with resistance and Q3 looks weak. More 

Stocks Move Back in the Red Ahead of Earnings

Stocks took a haircut to move back in the red on continued weakness in biotech, while YUM and ADBE missed earnings and slashed guidance. More 

Be Careful Before Loving Leveraged Biotech ETFs

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. More 

3 Bear Plays for the Bust in Biotech Stocks

The bull in biotech stocks is dead. Embrace the new bearish overlords with put plays on these three biotechs. More